This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
BioPharm America is merging with LSX USA
Hynes Convention Center | Boston, MA

September 11–12, 2024

Kyle Bartholomew
Director of Investments at NCBiotech


Kyle Bartholomew is a Director of Investments with the Emerging Company Development team at NCBiotech. In this role he In this role, he identifies and evaluates promising early-stage life science companies for NCBC loans. Kyle provides business strategy support to portfolio companies to help them raise follow-on investment capital and grow their business in North Carolina.

Kyle has more than 10 years of experience in the life sciences as a scientist, licensing professional, and business strategist. As a Commercialization Manager in the Office of Technology Commercialization at UNC-Chapel Hill Kyle worked to translate novel discoveries and inventions from UNC research into products that improve human health. Subsequent to his time at UNC-Chapel Hill, Kyle worked as a management consultant in the life sciences industry advising companies on topics such as commercial opportunity assessment, pricing and market access, and therapeutic portfolio optimization.

Agenda Sessions

  • Startup Spotlight